A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells

BACKGROUND: The acquisition of drug resistance is a major reason for poor outcome of neuroblastoma. Protein kinase C (PKC) has been suggested to influence drug resistance in cancer cells. The aim of this study was to elucidate whether inhibition of PKCβ isoforms influences drug-resistance of neurobl...

Descripción completa

Detalles Bibliográficos
Autores principales: Svensson, Karin, Larsson, Christer
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153510/
https://www.ncbi.nlm.nih.gov/pubmed/12697075
http://dx.doi.org/10.1186/1471-2407-3-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153510/
https://www.ncbi.nlm.nih.gov/pubmed/12697075
http://dx.doi.org/10.1186/1471-2407-3-10

Ejemplares similares